Publications by authors named "Vishnu Murthy"

Claim this Profile
L
Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [Lu]Lu-PSMA-617: A Single-Center Retrospective Study.
Vishnu Murthy, Koichiro Kimura, Lela Theus, Andrew Nguyen, Tristan R Grogan

J Nucl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with Lu-PSMA: A Retrospective, Single-Center Study.
Vishnu Murthy, Koichiro Kimura, Lela Theus, Andrew Nguyen, Ojaswita Lokre

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy.
Vishnu Murthy, Vinicius Ludwig, Andrei Gafita, Thomas A Hope, Jeremie Calais

J Nucl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer.
Daniel Hyeong Seok Kim, Ida Sonni, Tristan Grogan, Anthony Sisk, Vishnu Murthy

Radiol Imaging Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing insects mediated plastic biodegradation: Current insight and future directions.
Jasti Sri Vishnu Murthy, Alagesan Keerthana, K Logeswaran, Abhibandana Das, Srishti Choudhury

J Environ Manage· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Toxicity of [Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data.
Vishnu Murthy, Andrew F Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.
Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan

J Nucl Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study.
Vishnu Murthy, Emmanuel Appiah-Kubi, Kathleen Nguyen, Pan Thin, Masatoshi Hotta

Eur J Hybrid Imaging· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA-Negative Lesion Progression Under Lu-PSMA Radioligand Therapy.
Vishnu Murthy, Martin Allen-Auerbach, Richard Lam, Dawn Owen, Johannes Czernin

J Nucl Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study.
Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias R Benz, Ida Sonni

J Nucl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer.
Lisa M Gudenkauf, Melody N Chavez, Melinda Leigh Maconi, Carley Geiss, Ameen Seyedroudbari, Vishnu Murthy

J Nucl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.
Andrei Gafita, Isabel Rauscher, Wolfgang P Fendler, Vishnu Murthy, Wang Hui

Eur J Nucl Med Mol Imaging· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Role of Next-Generation Imaging in Prostate Cancer.
Vishnu Murthy, Rahul Aggarwal, Phillip J Koo

Curr Oncol Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
Thomas A Hope, Matthias Eiber, Wesley R Armstrong, Roxanna Juarez, Vishnu Murthy

JAMA Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer.
Vishnu Murthy, Ida Sonni, Namasvi Jariwala, Roxanna Juarez, Robert E Reiter

Eur Urol Focus· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
Wolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, Matthias Eiber, Robert R Flavell, Vishnu Murthy

J Nucl Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do public health activities pay for themselves? The effect of county-level public health expenditures on county-level public assistance medical care benefits in California.
Timothy Tyler Brown, Vishnu Murthy

Health Econ· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ga-PSMA-11 PET/MRI: determining ideal acquisition times to reduce noise and increase image quality.
Vishnu Murthy, Raven L Smith, Dora H Tao, Courtney A Lawhn-Heath, Dave E Korenchan

EJNMMI Phys· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of RP-UPLC method for the determination of darifenacin hydrobromide, its related compounds and its degradation products using design of experiments.
M Vishnu Murthy, Ch Krishnaiah, K Srinivas, K Srinivasa Rao, N Ramesh Kumar

J Pharm Biomed Anal· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a stability-indicating LC method for determining palonosetron hydrochloride, its related compounds and degradation products using naphthalethyl stationary phase.
M Vishnu Murthy, Katkam Srinivas, Ramesh Kumar, K Mukkanti

J Pharm Biomed Anal· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms.
Ch Krishnaiah, M Vishnu Murthy, Ramesh Kumar, K Mukkanti

J Pharm Biomed Anal· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis